[Severe adverse events from treatment with genetically engineered biological agents in patients with rheumatic diseases].
Moiseev SV, Novikov PI, Semenkova EN, Strizhakov LA, Gulyaev SV, Yanushkevich TN, Nikiforova NV, Meshkov AD, Panasyuk VV, Sokorin YD, Taranova MV, Parfenova SA, Dubrovskaya LV, Zhabina ES, Kuznetsova EI, Lopatina IA, Bulanov NM, Mukhin NA.
Moiseev SV, et al. Among authors: meshkov ad.
Ter Arkh. 2013;85(5):37-43.
Ter Arkh. 2013.
PMID: 23819337
Clinical Trial.
Russian.